NewslettersCell Therapy NewsChimeric Antigen Receptor (CAR) T-Cell Therapy: Engineering Immune Cells To Treat Liver DiseasesBy Noshin Noorjahan - June 26, 20250133The authors present an overview of CAR technology’s fundamental principles and achievements, focusing on CAR-T cell applications in hepatic viral infections, autoimmune liver disease, and hepatobiliary tumors.[Journal of Hepatology]Full Article